AMR Sept Banner v2

ASM Attends UN General Assembly

ASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.
Read

UN General Assembly Focuses on AMR

Leaders at the UN General Assembly draft a plan for coordinated, cross-cutting efforts to improve the current state of AMR.
Read

Superbugs are a 'Fundamental Threat'

If antibiotics were telephones, we would still be calling each other using clunky rotary dials and copper lines," Stefano Bertuzzi, CEO of ASM, told NBC News.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

liu junDr. Liu's work lies in the interdisciplinary area of chemical biology. His lab has elucidated the molecular mechanism of action of number of bioactive natural products of microbial origin. He and others discovered the type 2 methionine aminopeptidase as the target of the anti-angiogenic natural products fumagillin and ovalicin. His group also discovered that antitumor natural product lactimidomycin binds to the larger subunit of ribosome, blocking the elongation step of eukaryotic translation similar to cycloheximide. His lab has also identified, through high-throughput screening, a number of inhibitors of the methionine aminopeptidase family of enzymes that showed promising antimalarial and anti-mycobacterial activities.

 

Link to Group Website: http://www.hopkinsmedicine.org/pharmacology/research/liu.html

TPL_asm2013_SEARCH

91119